Your browser doesn't support javascript.
loading
Preferential expansion of cross-reactive pre-existing switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
Cory A Perugino; Hang Liu; Jared Feldman; Blake M Hauser; Catherine Jacob-Dolan; Anusha Nathan; Zezhou Zhou; Clarety Kaseke; Rhoda Tano-Menka; Matthew A Getz; Fernando Sanjobe; Cristhian Berrios; Onosereme Ofoman; Jacob Lemieux; Marcia B. A Goldberg; Kerstin Nundel; Ann Marshak-Rothstein; John Iafrate; Gaurav Gaiha; Richelle Charles; Alejandro B Balazs; Vivek Naranbhai; Aaron G Schmidt; Shiv Pillai.
Afiliação
  • Cory A Perugino; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital
  • Hang Liu; Ragon Institute of MGH, MIT and Harvard
  • Jared Feldman; Ragon Institute of MGH, MIT and Harvard
  • Blake M Hauser; Ragon Institute of MGH, MIT and Harvard
  • Catherine Jacob-Dolan; Ragon Institute of MGH, MIT and Harvard
  • Anusha Nathan; Ragon Institute of MGH, MIT and Harvard
  • Zezhou Zhou; Ragon Institute of MGH, MIT and Harvard
  • Clarety Kaseke; Ragon Institute of MGH, MIT and Harvard
  • Rhoda Tano-Menka; Ragon Institute of MGH, MIT and Harvard
  • Matthew A Getz; Ragon Institute of MGH, MIT and Harvard
  • Fernando Sanjobe; Ragon Institute of MGH, MIT and Harvard
  • Cristhian Berrios; Department of Pathology, Massachusetts General Hospital
  • Onosereme Ofoman; Department of Pathology, Massachusetts General Hospital
  • Jacob Lemieux; Infectious Diseases Division, Massachusetts General Hospital
  • Marcia B. A Goldberg; Massachusetts General Hospital
  • Kerstin Nundel; University of Massachusetts Medical School
  • Ann Marshak-Rothstein; University of Massachusetts Medical School
  • John Iafrate; Department of Pathology, Massachusetts General Hospital
  • Gaurav Gaiha; Gastrointestinal Unit, Massachusetts General Hospital
  • Richelle Charles; Infectious Diseases Division, Massachusetts General Hospital
  • Alejandro B Balazs; Ragon Institute of MGH, MIT and Harvard
  • Vivek Naranbhai; Massachusetts General Hospital/ Dana Farber Cancer Institute
  • Aaron G Schmidt; Ragon Institute of MGH, MIT and Harvard
  • Shiv Pillai; Ragon Institute, Massachusetts General Hospital
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21268554
ABSTRACT
In previously unvaccinated and uninfected individuals, non-RBD SARS-CoV-2 spike-specific B cells were prominent in two distinct, durable, resting, cross-reactive, "pre-existing" switched memory B cell compartments. While pre-existing RBD-specific B cells were extremely rare in uninfected and unvaccinated individuals, these two pre-existing switched memory B cell compartments were molded by vaccination and infection to become the primary source of RBD-specific B cells that are triggered by vaccine boosting. The frequency of wild-type RBD-binding memory B cells that cross-react with the Omicron variant RBD did not alter with boosting. In contrast, after a boost, B cells recognizing the full-length Omicron variant spike protein expanded, with pre-existing resting memory B cells differentiating almost quantitatively into effector B cell populations. B cells derived from "ancient" pre-existing memory cells and that recognize the full-length wild-type spike with the highest avidity after boosting are the B cells that also bind the Omicron variant spike protein. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=141 SRC="FIGDIR/small/21268554v1_ufig1.gif" ALT="Figure 1"> View larger version (32K) org.highwire.dtl.DTLVardef@1de97acorg.highwire.dtl.DTLVardef@b7ab7forg.highwire.dtl.DTLVardef@5c38dcorg.highwire.dtl.DTLVardef@99106c_HPS_FORMAT_FIGEXP M_FIG C_FIG
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Rct Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Rct Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
...